AMERICAN SOCIETY OF CONSULTANT PHARMACISTS for AMERICAN SOCIETY OF CONSULTANT PHARMACISTS
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 4th Quarter - Report (this page) | Jan 23, 2017 | $40,000 | Replaced |
| 4th Quarter - Amendment | Feb 22, 2017 | $40,000 | Yes |
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Pharmacy Lock-in (s.1913, S.524), Pharmacy provider status (H.R. 592/S.314),
| Lobbyist | Covered position, as disclosed |
|---|---|
| PETER RANKIN | Director of Policy and Advocacy |
Medicare/Medicaid MMM
HR592/S314 Pharmacy and Medically Underserved Areas Enhancement Act,
| Lobbyist | Covered position, as disclosed |
|---|---|
| PETER RANKIN | — |
Pharmacy PHA
H.R. 592/S.314 Pharmacy and Medically Underserved Areas Enhancement Act, Impact Act Implementation, Repackaging and compounding guidance, controlled substances act requirements for electronic e-kits.
| Lobbyist | Covered position, as disclosed |
|---|---|
| PETER RANKIN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.